Tag: Cancer: Brain
Variation Seen in Hospice Use for Malignant Glioma
Differences by race, sex, age, level of education, urban versus rural residence identified
Drug Combo Doesn’t Lengthen Glioblastoma Survival
Lomustine+bevacizumab may increase progression-free, but not overall, survival versus lomustine alone
Overall Survival Up for Melanoma Brain Metastases
Median overall survival from time of diagnosis has increased from 7.5 to 22.7 months
Vaccine-Chemotherapy Combo Promising in Glioblastoma
Four of the 11 patients in study survived for more than five years after vaccine/chemo treatment
AACR: TTFields + Temozolomide Ups Survival in Glioblastoma
Compliance with TTFields treatment predicts outcome, with better outcome for >18 hour/day
Study Finds No Link Between Cytomegalovirus, Glioblastoma
Researchers find no evidence of cytomegalovirus in tumor tissue
Case Report: Adoptive T-Cell Tx Shows Promise in Glioblastoma
Tumors regressed after intracranial infusions of T cells engineered to target tumor-associated antigen
Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome
Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS
Less Cognitive Deterioration With Stereotactic Radiosurgery Alone
Results seen in patients with one to three brain metastases
Gross Total Resection for the Best Results in Glioblastoma
Although larger procedure carries more risk, odds of longer survival are higher
